RE:RE:RE:FSD Pharma patent expires 2034You did not read correctly. I did NOT say 5000 Covid drugs. I said out of 5000 drugs that go to trial testing period of all drugs through FDA only 5 make it through. Saying the percentage is low. Oh and there are hundreds of drugs going through Covid testing right now not 20 lol. Hundreds. For all sorta of reasons from vaccine to inflammatory issues. FSD is not unique in going to the FDA with a potential drug. Give your head a shake. MicroPea has some potential absolutely. But don't pretend it's one of 20.
AntiBasherr wrote: You are insane with your misinformation
There are only 20 companies doing covid19 research. Your high output numbers are not accurate stick with the facts.
IF FSD ever passes phase 2a and 2b with good results this will be amazing not only for shareholders but for patients if they can prove it helps with the cytokine storm.
Bigmac4000 wrote: You are copy and pasting your same same exact speeches. It's 2030 patent ending and the phase trials take years to complete. Probably 2025 at earliest. Out of 5000 drugs trials only 5 make it to shelf. You left out those details. I was just helping you out.
AntiBasherr wrote: There are only a handful of companies that have the patent 2034 protected process of ultramicronized microPEA basically only Epitech and FSD Pharma. Epitech will control the Italian and Spanish markets and I see FSD wants to target the rest of the world for their compound.